Search Results - "Burkes, R."

ASO Visual Abstract: Two-Year Outcomes After Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer-The QuickSilver Study.

Authors: Kennedy ED Simunovic M Schmocker S et al.

Corporate Authors: Kennedy ED Simunovic M Schmocker S et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Jul 05. Date of Electronic Publication: 2026 Jul 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

AUTHOR INDEX.

Source: Asia Pacific Journal of Clinical Oncology. Nov2017 Supplement S5, Vol. 13, p225-235. 11p.

Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

Authors: Özdemir, Özlem Günenç, Damla Taşkaynatan, Halil et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3979. 17p.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025.

Authors: Ahmed, Arwa Mercier, Stéphanie L. Ramjeesingh, Ravi et al.

Source: Current Oncology. Apr2026, Vol. 33 Issue 4, p228. 26p.

Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy.

Authors: Steup, Christoph Mondorf, Antonia Wild, Peter et al.

Source: PLoS ONE. 7/6/2026, Vol. 21 Issue 7, p1-17. 17p.

Critical Prognostic and Predictive Factors in Colorectal Liver Metastasis: A Thorough Analysis of Existing Literature and Future Outlook.

Authors: Pasca, Paul Faur, Flaviu Ionut Burta, Cosmin et al.

Source: Journal of Clinical Medicine. Jul2026, Vol. 15 Issue 13, p4907. 22p.

A Clinical and Molecular Comparative Analysis of KRAS Exon 2 and KRAS Non-Exon 2 Mutated Colorectal Cancer.

Authors: Kahramangil Baytar, Doga Zinser-Peniche, Paola Wang, Shuaichao et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2158. 14p.

Impact of Driver Genetic Alterations on Survival in Metastatic Colorectal Cancer Patients from a Genetically Homogeneous Sardinian Population: A Real-World Study.

Authors: Palomba, Grazia Nuvoli, Luca Sini, Maria Cristina et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1708. 15p.

Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study.

Authors: Russ, E. Ziemons, J. Hillege, L. E. et al.

Source: BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-8. 8p.

An efficient total synthesis of vilanterol: an inhaled drug.

Authors: Kamireddy, Kamalaker Reddy Gogula, Sailam Sri Banoji, Venkateswarlu et al.

Source: ARKIVOC: Online Journal of Organic Chemistry. 2023, Vol. 2023, p1-10. 102p.

Transplant Oncology in Evolution: Emerging Roles for Liver Transplant Beyond Hepatocellular Carcinoma.

Authors: Abdelhakeem, Ahmed A. O'donnell, Conor D. Elantably, Dina et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p887. 19p.

Regional Therapies Utilized in Treating Unresectable Colorectal Adenocarcinoma with Peritoneal Metastases.

Authors: Malik, Shray Le, Vanessa Dayyani, Farshid et al.

Source: Cancers. Mar2026, Vol. 18 Issue 5, p863. 16p.

BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

Authors: Taniguchi, Hiroya Uehara, Kay Ishikawa, Toshiaki et al.

Source: Cancers. Feb2025, Vol. 17 Issue 3, p399. 15p.

Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study.

Authors: Ishii, Masatsugu Itano, Osamu Iwamoto, Hideki et al.

Source: PLoS ONE. 11/6/2025, Vol. 20 Issue 11, p1-12. 12p.

PrP C -Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced RAS-GTP and AKT/ERK Phosphorylation.

Authors: Lee, Jeong Kun Yoon, Jun Young Lee, Jae Young et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 3, p1159. 16p.

Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapy.

Authors: Yang, Mingli Schell, Michael J. Salk, Jesse J. et al.

Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-19. 19p.

Refining Outcomes in Technically Resectable Colorectal Liver Metastases: A Simplified Risk Model and the Role of Preoperative Chemotherapy.

Authors: Kanesada, Kou Nakajima, Masao Ioka, Tatsuya et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p227. 16p.

Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors †.

Authors: Lapuk, Anna Furman, Benjamin L. S. Feijao, Pedro et al.

Source: Current Oncology. Jan2026, Vol. 31 Issue 1, p18. 20p.

Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal Cancer.

Authors: Chibaudel, Benoist Carola, Elisabeth Mekranter, Hamid et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p8. 16p.

Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Authors: King, Gentry G. Baker, Kelsey K. Coveler, Andrew L. et al.

Source: Cancers. Jun2025, Vol. 17 Issue 11, p1830. 18p.